Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,880 | 167,953 | 173,622 | 138,768 | 181,045 |
| Receivables | 154,726 | 141,113 | 137,565 | 130,986 | 133,758 |
| Inventories | 33,979 | 30,537 | 33,762 | 32,652 | 32,184 |
| TOTAL | $350,241 | $363,616 | $373,971 | $335,777 | $390,537 |
| Non-Current Assets | |||||
| PPE Net | 104,223 | 101,957 | 100,680 | 99,668 | 98,784 |
| Intangibles | 162,877 | 163,128 | 163,408 | 163,686 | 155,120 |
| Other Non-Current Assets | 32,900 | 16,328 | 14,602 | 15,019 | 13,725 |
| TOTAL | $300,000 | $281,413 | $278,690 | $278,373 | $267,629 |
| Total Assets | $650,241 | $645,029 | $652,661 | $614,150 | $658,166 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 147,543 | 198,193 | 216,787 | 212,915 | N/A |
| Accounts payable and accrued liabilities | 44,710 | 38,509 | 39,528 | 36,526 | 33,009 |
| Accrued Expenses | 28,621 | 29,186 | 23,140 | 24,302 | 24,368 |
| TOTAL | $280,274 | $323,405 | $337,412 | $328,809 | $106,408 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,864 | 16,099 | 21,871 | N/A | N/A |
| Deferred Revenues | 20,181 | 14,923 | 18,472 | 23,616 | 16,528 |
| Other Non-Current Liabilities | 53,239 | 49,300 | 50,600 | 51,019 | 53,036 |
| TOTAL | $77,627 | $73,634 | $80,856 | $58,628 | $270,000 |
| Total Liabilities | $357,901 | $397,039 | $418,268 | $387,437 | $376,408 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,067 | 44,924 | 44,676 | 44,652 | 44,617 |
| Common Shares | 1,397 | 1,396 | 1,430 | 1,430 | 1,430 |
| Retained earnings | 536,991 | 519,052 | 530,500 | 498,963 | 469,454 |
| Other shareholders' equity | -3,048 | -3,458 | -3,686 | -3,728 | -3,845 |
| TOTAL | $292,340 | $247,990 | $234,393 | $226,713 | $281,758 |
| Total Liabilities And Equity | $650,241 | $645,029 | $652,661 | $614,150 | $658,166 |